Autoimmune-featured interstitial lung disease: a distinct entity.
about
Idiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural historyIdiopathic interstitial pneumonias with connective tissue diseases features: A reviewInterstitial lung disease in undifferentiated forms of connective tissue diseaseRole of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF).Interpretation of autoantibody positivity in interstitial lung disease and lung-dominant connective tissue diseaseCharacterisation of patients with interstitial pneumonia with autoimmune features.Pulmonary function and survival in idiopathic vs secondary usual interstitial pneumonia.Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia.Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosisInfluence of autoimmune biomarkers on interstitial lung diseases: A tertiary referral center based case-control study.Clinical characteristics and survival in idiopathic pulmonary fibrosis and connective tissue disease-associated usual interstitial pneumonia.Normalization of lung function following treatment of secondary usual interstitial pneumonia: a case report.Lung-dominant connective tissue disease among patients with interstitial lung disease: prevalence, functional stability, and common extrathoracic featuresGenetics of Interstitial Lung Disease: Vol de Nuit (Night Flight).Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung diseaseThyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary FibrosisClinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic SclerosisLong-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy.Connective Tissue Disease-associated Interstitial Lung Disease: A review.Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosisInterstitial lung diseases in Saudi Arabia: A single-center study.Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.Respiratory failure in a patient with dermatomyositis.Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune featuresComparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrosIdiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations.BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease.COPD is associated with production of autoantibodies to a broad spectrum of self-antigens, correlative with disease phenotype.Organizing pneumonia preceding rheumatoid arthritis.Diagnostic workup for diffuse parenchymal lung disease: schematic flowchart, literature review, and pitfalls.Fibrosing interstitial lung disease. A practical high-resolution computed tomography-based approach to diagnosis and management and a review of the literature.Molecular biomarkers in interstitial lung diseases.Idiopathic non-specific interstitial pneumonia.Recent advances in connective tissue disease related interstitial lung disease.Interstitial Pneumonia With Autoimmune Features: Value of Histopathology.Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias.Dynamic expression of transformating growth factor-β1 and caveolin-1 in the lung of Bleomycin-induced interstitial lung disease.Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS?Interstitial lung disease in suggestive forms of connective tissue disease
P2860
Q26776473-59864601-D437-4E43-9B28-EBEFC5501DFFQ26799465-F67E3825-A313-4F16-A402-CD2A32921729Q26860702-053FCCF9-9165-4218-AB4C-890BC79B9411Q33737250-0DFA6BB7-D205-4388-BF5B-B7FA5C66BABFQ33824245-6ECE3935-93FA-425A-B9DB-318A933558F8Q33915673-D6C75683-BC52-486B-BD93-1E955674E6C0Q34118274-8D0FCBE2-A071-418E-8C6B-A5A4D37A3AC3Q34687520-E7639709-9AE0-411C-A176-CED4E318E154Q35149295-F297A270-1229-427B-9AB8-973B3A10CC60Q35151957-5370448D-3934-40FE-B38C-CD80675B5365Q35290722-8C38A88F-2365-4303-B4E8-8C0A21E62D2FQ35459151-D3ABF355-E3F1-4921-92F9-D9603FFB745DQ35597810-81691B49-9B8C-43F7-8093-CBC08971C7ADQ35649228-29D1F2C0-8B28-40A0-AE40-6EBA246C62CBQ35794515-2D1C942F-0100-4ED5-B531-E13417439D1BQ36015454-7534E710-CA06-4C75-9122-22BA9FD732B9Q36114308-BA8E5064-607C-4E55-98B7-3A33BA55EE81Q36208495-7A3764D9-8F0A-44EE-8FC4-F0138129E507Q36363696-6DCCA838-5888-4ED3-9697-0F0BA30A1A2DQ36527477-5D411B9B-5603-4197-929D-C8C184CE6286Q36613024-5281EA7C-0AA5-485C-A0E8-B3AE1DEF4BC0Q36664408-8A95B339-DCDD-4622-B208-FE1EF42AE797Q36749685-D7820DFE-8982-4D7C-B80C-7D1CEE152F3FQ36837811-090F0D2B-3BF6-423D-8A28-40D16FB707CEQ37220222-3EBE6836-FC98-4F08-874A-779E65CA57EEQ37237739-F23CD7E2-FF15-4928-AEFA-A4D7D9CA40D6Q37438932-C834D685-34B7-4364-8676-458B8BA27743Q37572312-3BFCDF87-D720-4D14-B31A-08B8D866742CQ37588108-0BD5E1E5-D394-4C64-9B4E-22404C0688EBQ38059610-8AD0C6F4-661C-4B45-826B-94CB76D2D663Q38106756-974802D2-5751-460B-A023-42D5B254C809Q38220769-3AF5C2CC-8E47-4152-B3CC-B40AB3B571E7Q38632441-671D0AF5-AB66-4484-9C18-6FAA2BEE8985Q38678939-2ADA163E-FFE1-4961-BA3E-906D39014847Q39280415-182E5DB1-D91E-4D29-8271-38B148C68701Q40289711-7AAFCD5B-6646-4F09-AE40-811ED32A2993Q40912037-ECC42374-496A-423D-A69D-B76A902B9143Q41303019-C830B3A4-3C88-491E-A591-D3E091D071D0Q41681887-C7DAFF4E-881E-4591-9AA0-B21E78E2698FQ42715014-3D542548-57EE-40F4-9A81-A4B93B41AD3F
P2860
Autoimmune-featured interstitial lung disease: a distinct entity.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Autoimmune-featured interstitial lung disease: a distinct entity.
@ast
Autoimmune-featured interstitial lung disease: a distinct entity.
@en
type
label
Autoimmune-featured interstitial lung disease: a distinct entity.
@ast
Autoimmune-featured interstitial lung disease: a distinct entity.
@en
prefLabel
Autoimmune-featured interstitial lung disease: a distinct entity.
@ast
Autoimmune-featured interstitial lung disease: a distinct entity.
@en
P2093
P2860
P356
P1433
P1476
Autoimmune-featured interstitial lung disease: a distinct entity.
@en
P2093
Mary E Strek
P2860
P304
P356
10.1378/CHEST.10-2662
P407
P577
2011-05-12T00:00:00Z